Are you above the legal age to view this content in your province/state?

Home / Industry News / Stocks and Founds that are overexposed To Russia And Ukraine

Stocks and Founds that are overexposed To Russia And Ukraine

Stock markets worldwide have been in red since Russia began its invasion of Ukraine last week, and American and European companies that have a significant presence in Russia have been hit particularly hard.

The S&P 500 Index is down 4.6% since the start of February as Russia escalated the conflict. But that is nothing compared to Newtown, PA’s EPAM Systems, a software development and consulting firm that crashed 45.6% on Monday after withdrawing its 2022 financial outlook. It was the S&P 500 index’s biggest loser for the month.

Arkadiy Dobkin, a Belarusian immigrant, started the company in Princeton, NJ in 1993 and later moved its headquarters to Pennsylvania, but maintained deep roots in Eastern Europe. 

EPAM disclosed in its annual report Friday night that about 14,000 of its 58,824 employees at the end of 2021 were in Ukraine, plus another 18,350 delivery professionals in Russia and Belarus.

“EPAM’s highest priority is the safety and security of its employees and their families in Ukraine,” the software firm said in a statement Monday. “The company is proactively working to relocate its employees to lower risk locations in Ukraine and neighboring countries.”

In the Atlantic Ocean, Dutch telecom company Veon has crashed more than 70% in the last month, with its market cap falling to less than $1 billion.

 Veon’s Beeline network in Russia generates half of the firm’s $7.8 billion in annual sales, and its largest shareholder, billionaire Mikhail Fridman, resigned from its board after he was one of 26 oligarchs sanctioned by the European Union on Monday.



Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Investment Value Finders is intended for those 21+ years of age only!

Check Also

FSD PHARMA signs agreement with Covar Pharmaceuticals to support the development of LUCID

FSD Pharma Inc., a life sciences holding company dedicated to building a portfolio of assets …